Firalis - Posts

Home
About
Services
R&D
Products
Quality
Investors
Media
Careers
IFU APO-Easy
Copy of IFU APO-Easy
Stability APO-Easy
APO-Easy-FLS-OE02-01
APO-Easy-FLS-OE02-02
APO-Easy-FLS-OE02-03

Home
About
Services
Products
R&D
Quality
Investors
Media

Posts

COVIRNA Project Final Conference takes place on 19-April-23

COVIRNA Project end date is approaching, with the final conference that will take place in Brussels on the 19th of April, 2023.

07.04.2023

PARADISE Project launches with a kick-off held in Dublin (3-4 April 2023)

To develop a personalised prediction tool for better management of autoimmune diseases recurrence, PARADISE Project kicked off on 3 -4 April 2023 in Dublin, coordinated by ADAPT at Trinity College of Dublin, with partners across several European institutions, including FIRALIS.

05.04.2023

Reasons for hope on World Alzheimer’s Day

21st September : World Alzheimer's Day. 📅

21.09.2021

RNAs to predict COVID-19's cardiovascular outcomes

Check out the video presentation of COVIRNA Consortium

19.07.2021

EASYCOV: INAUGURATION DE LA LIGNE DE PRODUCTION

Firalis a inauguré la ligne de production automatisée, dédiée au production de "EasyCOV", le test rapide salivaire de dépistage du Covid-19 !

09.12.2020

Firalis against Covid-19 !

20.03.2020

Contact Firalis

Firalis Group

The company logos, products and service marks are trademarks or registered trademarks of Firalis.

-----------------------------------------------------------------------------------------------------------------------

Information addressed to health professionals. The products presented on this site are for professional use only and, where applicable, comply with the requirements of the IVD Directive 98/79 / EC. Instructions for use must be consulted before using these products.

-----------------------------------------------------------------------------------------------------------------------

Headquarter : 17 Rue du Fort 68330 Huningue FRANCE